Initial public offering nets $79mm for Aprea

15:40 EDT 4 Oct 2019 | Elsevier Business Intelligence

Oncology firm Aprea Therapeutics Inc. completed its initial public offering, netting $79mm through the sale of 5.67mm common ...

Original Article: Initial public offering nets $79mm for Aprea


More From BioPortfolio on "Initial public offering nets $79mm for Aprea"

Quick Search

Relevant Topic

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...